Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study (Q43209177)

From Wikidata
Jump to navigation Jump to search
scientific article published on 23 December 2009
edit
Language Label Description Also known as
English
Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study
scientific article published on 23 December 2009

    Statements

    Safety, tolerability, and clinical outcomes after intraarticular injection of a recombinant adeno-associated vector containing a tumor necrosis factor antagonist gene: results of a phase 1/2 Study (English)
    0 references
    Stephen A Bookbinder
    Craig W Wiesenhutter
    Eric M Ruderman
    Joseph Z Forstot
    Michael J Maricic
    Charles H Pritchard
    Darrell N Fiske
    Francis X Burch
    Pervin Anklesaria

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit